Lumos Diagnostics Holdings Limited (ASX:LDX)
Australia · Delayed Price · Currency is AUD 0.2550
-0.0050 (-1.92%)
Feb 26, 2026, 4:10 PM AEST
ASX:LDX Market Cap
ASX:LDX has a market cap or net worth of 206.24 million as of February 25, 2026. Its market cap has increased by 884.01% in one year.
Market Cap
206.24M
Enterprise Value
213.91M
Revenue
18.91M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.26
Market Cap Chart
Since July 5, 2021, ASX:LDX's market cap has increased from 196.70M to 206.24M, an increase of 4.85%. That is a compound annual growth rate of 1.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 206.24M | -8.08% |
| Dec 31, 2025 | 224.36M | 756.38% |
| Dec 31, 2024 | 26.20M | -25.44% |
| Dec 29, 2023 | 35.13M | 248.53% |
| Dec 30, 2022 | 10.08M | -93.27% |
| Dec 31, 2021 | 149.80M | -23.85% |
| Jul 5, 2021 | 196.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anteris Technologies Global | 779.80M |
| PolyNovo | 635.58M |
| Aroa Biosurgery | 241.83M |
| EMVision Medical Devices | 162.64M |
| SomnoMed | 154.00M |
| Cleo Diagnostics | 74.59M |
| Compumedics | 69.92M |
| Micro-X | 51.55M |